# BioNova Pharmaceuticals (Shanghai)

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bionova-pharmaceuticals-shanghai

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: http://www.bionovapharma.com
- Latest round: Series B (Nov 23, 2020)
- Investors on record: 10

## About

Based in Shanghai, China and established in 2018, BioNova Pharmaceuticals (Shanghai) Ltd. is a company mainly engaged in the wholesale of pharmaceuticals and the operation of Class III medical devices. The company's headquarter covers an area of 7,200 square meters, and now has 15 large pharmacies and outpatient clinics and other cooperative units, and has several medical insurance designated pharmacies. In November 2020, it closed a round of strategic investment.

The products and services offered by the company include wholesaling of pharmaceuticals and operation of Class III medical devices. The company has a pharmaceutical enterprise information management system, a warehouse management system, a PDA picking system, a task assignment system, a Pan-Micro office system, a FanSoft reporting system, etc. It also has a logistics fleet to help it deliver medicines to its customers.

## Funding rounds

- Series B, Nov 23, 2020 — GP Capital, Rencent International Asset Management, MED-FINE Capital, Hanne Capital
- Series B, Aug 1, 2020 — OrbiMed Advisors, Mitsui Global Investment, Lilly Asia Ventures, MED-FINE Capital, BioTrack Capital
- Series A, Dec 1, 2018 — Hillhouse Investment, TF Capital

## Investors

- Hillhouse Investment (https://capitalatlas.ai/funds/hillhouse-investment) — Series A
- TF Capital — Series A
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series B
- Mitsui Global Investment (https://capitalatlas.ai/funds/mitsui-global-investment) — Series B
- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series B
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Series B
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series B
- GP Capital (https://capitalatlas.ai/funds/gp-capital) — Series B
- Rencent International Asset Management — Series B
- Hanne Capital (https://capitalatlas.ai/funds/hanne-capital) — Series B